Gene · 54541
Papers3,069
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,069
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Therapeutic Potential of Baicalein in Endometrial Cancer: Suppression of mTOR Signaling and Synergy with Metformin. | Int J Mol Sci | 2025 | 41303544 | PubTator, text mining | PubMed |
| Identification and validation of PANoptosis-related biomarkers in Alzheimer's disease via single-cell RNA sequencing and machine learning. | Eur J Med Res | 2025 | 41291841 | PubTator, text mining | PubMed |
| Systems biology and experimental validation indicate DDIT4, FOXO1, and STAT3 as shared key genes linking osteoporosis and sarcopenia. | Front Genet | 2025 | 41282482 | PubTator, text mining | PubMed |
| ChaC1-based drug screenings identify a synergistic lethal effect of auranofin and proteasome inhibitors in hepatocellular carcinoma cells. | Cell Death Discov | 2025 | 41249117 | PubTator, text mining | PubMed |
| Bridging Genotype to Phenotype in KMT5B-Related Syndrome: Evidence from RNA-Seq, 18FDG-PET, Clinical Deep Phenotyping in Two New Cases, and a Literature Review. | Genes (Basel) | 2025 | 41153391 | PubTator, text mining | PubMed |
| Oroxin A Induces Autophagic Cell Death in Gastric Cancer Cells Through the MAPK/ERK/REDD1 Axis. | Cell Biol Int | 2025 | 41134029 | PubTator, text mining | PubMed |
| Tailor-made 3D in vitro maturation of early antral follicles uncovers cumulus-cell transcriptomic driver signature to predict oocyte competence. | Front Endocrinol (Lausanne) | 2025 | 41103659 | PubTator, text mining | PubMed |
| Bioinformatics differential expression analysis of the effect of cannabidiol in chronic myeloid leukaemia cell line. | Glob Med Genet | 2025 | 41080716 | PubTator, text mining | PubMed |
| REDD1 attenuates cholestatic liver fibrosis and suppresses PI3K/AKT/mTOR pathway. | Front Med (Lausanne) | 2025 | 41070072 | PubTator, text mining | PubMed |
| Corrigendum to "Paeonol regulates the DDIT4-mTOR signaling pathway in macrophages to promote diabetic wound healing" [Int. Immunopharmacol. 151 (2025) 114347]. | Int Immunopharmacol | 2025 | 41016872 | PubTator, text mining | PubMed |
| The m6A modification in cancer: roles, implications, and its potential in therapy. | Mol Biomed | 2025 | 40986143 | PubTator, text mining | PubMed |
| Correction: A review of the participation of DDIT4 in the tumor immune microenvironment through inhibiting PI3K-Akt/mTOR pathway. | Front Oncol | 2025 | 40978032 | PubTator, text mining | PubMed |
| A Machine Learning-Based Hypoxia-Related Gene Signatures to Facilitate Prediction of Cetuximab Response in Patients with Colorectal Cancer. | Int J Med Sci | 2025 | 40959565 | PubTator, text mining | PubMed |
| Advances in miRNA research: Unraveling the complexities of gene regulation. | Animal Model Exp Med | 2025 | 40947823 | PubTator, text mining | PubMed |
| Exploring the protective role of DDIT4/mTOR in podocyte integrity through macrophage polarization in diabetic kidney disease. | Ren Fail | 2025 | 40916492 | PubTator, text mining | PubMed |
| Theaflavins Inhibit Proliferation and Glycolysis of Colorectal Cancer Cells by Downregulating DDIT4. | Drug Dev Res | 2025 | 40911331 | PubTator, text mining | PubMed |
| A review of the participation of DDIT4 in the tumor immune microenvironment through inhibiting PI3K-Akt/mTOR pathway. | Front Oncol | 2025 | 40900790 | PubTator, text mining | PubMed |
| Long-read sequencing identifies ATXN3 repeat expansions, and transcriptomics reveals disease progression biomarkers and druggable targets for spinocerebellar ataxia type 3. | BMC Neurol | 2025 | 40890629 | PubTator, text mining | PubMed |
| Dissecting cross-lineage tumourigenesis under p53 inactivation through single-cell multi-omics and spatial transcriptomics. | Clin Transl Med | 2025 | 40887856 | PubTator, text mining | PubMed |
| Dual Impact of Iron Deficiency and Antibiotics on Host Metabolism: A Tissue-Level Analysis. | Metabolites | 2025 | 40863165 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54541/papers?page=6